CSIMarket Company Name, Ticker, Customers, else..
 



<< Back to Financial Strength by Company within Biotechnology & Pharmaceuticals Industry

Biotechnology & Pharmaceuticals Industry Financial Strength Information
Financial Strength Information & Trends  
 


Category:   Period:  

Biotechnology & Pharmaceuticals Industry 1 Q 4 Q 3 Q 2 Q 1 Q
  2023 2022 2022 2022 2022
Quick Ratio (TTM) 1.1 1.03 1.08 1.17 1.09
Quick Ratio Ranking # 12 # 11 # 14 # 10 # 8
Working Capital Ratio (TTM) 2.31 2.23 2.25 2.35 2.19
Working Capital Ratio Ranking # 12 # 7 # 18 # 11 # 10
Working Capital Per Revenue 0.49 0.45 0.44 0.44 0.42
Working Capital Per Revenue Ranking # 99 # 99 # 92 # 99 # 100
Leverage Ratio (TTM) 1.26 1.21 1.27 0.93 1.24
Leverage Ratio Ranking # 24 # 10 # 8 # 11 # 10
Total Debt to Equity (TTM) 0.68 0.63 0.32 0.03 0.42
Total Debt to Equity Ranking # 45 # 26 # 32 # 34 # 34
Interest Coverage (TTM) 9.41 7.9 7.48 12.35 11.9
Interest Coverage Ranking # 46 # 64 # 76 # 45 # 43
Debt Coverage (TTM) 0.34 0.27 0.54 5.43 0.63
Debt Coverage Ranking # 50 # 70 # 74 # 52 # 49

New: More Biotechnology & Pharmaceuticals Industry historic financial strength information >>

Quick Ratio Comment
On the trailing twelve months basis Current Liabilities decreased faster than Biotechnology & Pharmaceuticals Industry's Cash & cash equivalent, this led to improvement in Biotechnology & Pharmaceuticals Industry's Quick Ratio to 1.1 in the 1 Q 2023,, Quick Ratio remained below Biotechnology & Pharmaceuticals Industry average.



Within Healthcare sector only one Industry has accomplished higher Quick Ratio. Quick Ratio total ranking fell in contrast to the previous quarter from 11 to 12.

Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.

Quick Ratio Statistics as of 1 Q 2023
High Average Low
37.9 3.06 0.76
1. quarter 2016   4. quarter 2021

Quick Ratio Industry Ranking
Within: No.
Sector # 2
Overall # 12


Other Quick Ratios
Compare Industry's quick ratio to Yeti's or S&P Constituent list of Biotechnology & Pharmaceuticals Industry
Highest Ranking Quick Ratios Lowest Ranking Quick Ratios
Quick Ratios for YETI's Competitors Definiton of Quick Ratio


Biotechnology & Pharmaceuticals Industry Working Capital Ratio Statistics as of 1 Q 2023
 



Working Capital Ratio Statistics as of 1 Q 2023
High Average Low
4.83 2.52 1.7
1. quarter 2016   2. quarter 2021



Working Capital Ratio Comment
On the trailing twelve months basis Biotechnology & Pharmaceuticals Industry's Current Assets grew by 0.98 % in the 1 Q 2023 sequentially, while Current Liabilities decreased, this led to improvement in Industry's Working Capital Ratio to 2.31 in the 1 Q 2023, Working Capital Ratio remained below Biotechnology & Pharmaceuticals Industry average.



Within Healthcare sector only one Industry has achieved higher Working Capital Ratio. Working Capital Ratio total ranking has deteriorated relative to the previous quarter from 7 to 12.



Working Capital Ratio Industry Ranking
Within: No.
Sector # 2
Overall # 12

Other Working Capital Ratios
Highest Ranking Working Capital Ratios Lowest Ranking Working Capital Ratios
Compare Industry's Working Capital ratio to Yeti's or S&P Constituent list of Biotechnology & Pharmaceuticals Industry
Working Capital ratios for YETI's Competitors Definiton of Working Capital Ratio

Biotechnology & Pharmaceuticals Industry Working Capital Per Revenue Statistics as of 1 Q 2023
 
Working Capital Per Revenue Comment
On the trailing twelve months basis Biotechnology & Pharmaceuticals Industry's Working Capital Per Revenue sequentially grew to 0.49 in the 1 Q 2023, below Industry average. Due to decline in revenue year on year by -4.34%.



Within Healthcare sector 4 other industries have achieved lower Working Capital Per Revenue. Total ranking remained the same like in the preceding quarter at no. 99.




Working Capital Per Revenue Statistics as of 1 Q 2023
High Average Low
0.76 0.52 0.06
3. quarter 2016   1. quarter 2016


Working Capital Per Revenue Industry Ranking
Within: No.
Sector # 5
Overall # 99



Other Working Capital Per Revenue
Compare Industry's Working Capital Per Revenue to Yeti's or S&P Constituent list of Biotechnology & Pharmaceuticals Industry
Return On Assets for Biotechnology & Pharmaceuticals Industry Definiton of Working Capital Per Revenue



Biotechnology & Pharmaceuticals Industry Leverage Ratio Statistics as of 1 Q 2023
 


Leverage Ratio Statistics as of 1 Q 2023
High Average Low
3.16 1.45 -0.88
3. quarter 2020   1. quarter 2016



Leverage Ratio Comment
Despite repayements of liabilities of 2.74%, in 1 Q 2023, Liabilities to Equity ratio detoriated to 1.26, below Biotechnology & Pharmaceuticals Industry average.



In the Healthcare sector only one Industry has achieved lower Leverage Ratio.



Leverage Ratio overall ranking has fallen relative to the prior quarter from 10 to 24.



Leverage Ratio Industry Ranking
Within: No.
Sector # 2
Overall # 24

Other Leverage Ratios
Compare Industry's Leverage ratio to Yeti's or S&P Bond Interest rates
Highest Ranking Leverage Ratios Lowest Ranking Leverage Ratios
Leverage Ratios for YETI's Competitors What is Leverage Ratio?


Biotechnology & Pharmaceuticals Industry Total Debt to Equity Ratio Statistics as of 1 Q 2023
 
Debt to Equity Ratio Comment
Despite debt repayement of 6.42%, in 1 Q 2023 ,Total Debt to Equity detoriated to 0.68 in the 1 Q 2023, above Industry average.



Within Healthcare sector 2 other industries have achieved lower Debt to Equity Ratio. Debt to Equity Ratio total ranking has contracted relative to the preceding quarter from 26 to 45.




Debt to Equity Ratio Statistics as of 1 Q 2023
High Average Low
0.89 0.26 0.03
3. quarter 2014   2. quarter 2022



Debt to Equity Industry Ranking
Within: No.
Sector # 3
Overall # 45

Other Debt to Equity Ratios
Highest Ranking Debt to Equity Ratios Lowest Ranking Debt to Equity Ratios
Compare Industry's Debt to Equity ratio to Yeti's or S&P Definiton of Debt to Equity Ratio

Biotechnology & Pharmaceuticals Industry Interest Coverage Ratio Statistics as of 1 Q 2023
 


Interest Coverage Ratio Statistics as of 1 Q 2023
High Average Low
24.92 8.48 -89.62
2. quarter 2016   3. quarter 2016

Interest Coverage Ratio Comment
On the trailing twelve months basis Biotechnology & Pharmaceuticals Industry's ebitda grew by 24.63 % in 1 Q 2023 sequentially, faster than interest expenses, this led to improvement in Industry's Interest Coverage Ratio to 9.41 , above Biotechnology & Pharmaceuticals Industry average Interest Coverage Ratio.



In the Healthcare sector 2 other industries have accomplished higher Interest Coverage Ratio. Interest Coverage total ranking has improved so far to 46, from total ranking in previous quarter at 64.



Interest Coverage Ratio Industry Ranking
Within: No.
Sector # 3
Overall # 46

Other Interest Coverage Ratios
Highest Ranking Interest Coverage Ratios Lowest Ranking Interest Coverage Ratios
Compare Industry's Interest Coverage ratio to Yeti's or S&P Definiton of Interest Coverage Ratio


Biotechnology & Pharmaceuticals Industry Debt Coverage Statistics as of 1 Q 2023
 
Debt Coverage Ratio Comment
On the trailing twelve months basis Biotechnology & Pharmaceuticals Industry's ebitda grew by 24.63 % in 1 Q 2023 sequentially, faster than total debt, this led to improvement in Industry's Debt Coverage Ratio to 0.34 , Debt Coverage Ratio remained below Biotechnology & Pharmaceuticals Industry average.



Looking into Healthcare sector only one Industry has accomplished higher Debt Coverage Ratio. Debt Coverage Ratio total ranking has improved to 50, from total ranking in previous quarter at 70.




Debt Coverage Statistics as of 1 Q 2023
High Average Low
8.77 2.15 -0.13
3. quarter 2021   4. quarter 2015



Debt Coverage Industry Ranking
Within: No.
Sector # 2
Overall # 50

Other Debt Coverage Ratios
Highest Ranking Debt Coverage Ratios Lowest Ranking Debt Coverage Ratios
See also Biotechnology & Pharmaceuticals Industry's Margin Definiton of Debt Coverage Ratio

Date modified: 2023-05-25T19:26:19+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071